For centuries, opium has been a source of both profit and peril, its legacy entangled with addiction, imperialism, and the complex interplay of global trade and national development. While the illicit opium trade is infamous, the history of licit opium has remained largely untold.
Markets of Pain traces the global arc of licit opium from poppy fields and processing plants to the clinics and laboratories of modern medicine. It shows how both the Ottoman Empire and the Turkish Republic treated the opium poppy as a national resource. In postcolonial India, nationalist leaders initially rejected opium's imperial legacy before embracing its strategic value. At the heart of this story are the cultivators, scientists, bureaucrats, and policymakers who shaped the licit opium trade and grappled with its far-reaching consequences. Their work and visions demonstrate how colonial empires and postcolonial states helped forge the global pharmaceutical industry as it struggled to govern a drug it could not abandon.
Markets of Pain reveals how a seemingly marginal crop became an unlikely engine of modernization, a tool of Cold War geopolitics, and a harbinger of today's global opioid crisis. Benjamin Robert Siegel recovers a buried history with urgent relevance for global supply chains, international power, and public health.
